| 0 |
MALIGNANT NIPPLE NEOPLASM |
1 |
0.1111 |
| 1 |
PERIORBITAL INFLAMMATION |
1 |
0.0043 |
| 2 |
ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING |
1 |
0.0042 |
| 3 |
HYPERCALCAEMIA OF MALIGNANCY |
1 |
0.0037 |
| 4 |
COLON CANCER STAGE IV |
2 |
0.0034 |
| 5 |
NECROSIS ISCHAEMIC |
1 |
0.0022 |
| 6 |
DEVICE SAFETY FEATURE ISSUE |
2 |
0.0020 |
| 7 |
HYPERSENSITIVITY PNEUMONITIS |
2 |
0.0018 |
| 8 |
DEVICE OPERATIONAL ISSUE |
6 |
0.0014 |
| 9 |
DENTAL RESTORATION FAILURE |
1 |
0.0014 |
| 10 |
ADENOCARCINOMA GASTRIC |
1 |
0.0011 |
| 11 |
BLADDER CATHETERISATION |
1 |
0.0010 |
| 12 |
TONSILLAR DISORDER |
1 |
0.0009 |
| 13 |
PALMAR ERYTHEMA |
1 |
0.0009 |
| 14 |
ENDOCRINE DISORDER |
1 |
0.0008 |
| 15 |
TUMOUR PAIN |
1 |
0.0008 |
| 16 |
ANAL HAEMORRHAGE |
2 |
0.0007 |
| 17 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 18 |
LEUKAEMIA RECURRENT |
1 |
0.0006 |
| 19 |
FEMALE GENITAL TRACT FISTULA |
1 |
0.0006 |
| 20 |
FOOD INTERACTION |
1 |
0.0006 |
| 21 |
VULVOVAGINAL SWELLING |
1 |
0.0005 |
| 22 |
NAIL DISCOLOURATION |
2 |
0.0005 |
| 23 |
DEVICE CONNECTION ISSUE |
1 |
0.0005 |
| 24 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
1 |
0.0004 |
| 25 |
GASTROINTESTINAL TUBE INSERTION |
1 |
0.0004 |
| 26 |
ILEOSTOMY |
1 |
0.0004 |
| 27 |
CANCER PAIN |
1 |
0.0004 |
| 28 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 29 |
STOMA SITE DISCHARGE |
1 |
0.0004 |
| 30 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 31 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 32 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 33 |
B-CELL LYMPHOMA |
1 |
0.0003 |
| 34 |
FULL BLOOD COUNT ABNORMAL |
3 |
0.0003 |
| 35 |
CHEMOTHERAPY |
1 |
0.0003 |
| 36 |
DEVICE LEAKAGE |
11 |
0.0003 |
| 37 |
BLOOD DISORDER |
2 |
0.0002 |
| 38 |
RECURRENT CANCER |
1 |
0.0002 |
| 39 |
LEG AMPUTATION |
1 |
0.0002 |
| 40 |
BONE CANCER |
1 |
0.0002 |
| 41 |
NAIL DISORDER |
2 |
0.0002 |
| 42 |
IMMUNOSUPPRESSION |
2 |
0.0002 |
| 43 |
MYOSITIS |
2 |
0.0002 |
| 44 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 45 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 46 |
DEVICE DEFECTIVE |
3 |
0.0002 |
| 47 |
NEEDLE ISSUE |
5 |
0.0002 |
| 48 |
POLYNEUROPATHY |
2 |
0.0002 |
| 49 |
DEVICE DEPLOYMENT ISSUE |
2 |
0.0002 |
| 50 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 51 |
DRUG DOSE OMISSION BY DEVICE |
12 |
0.0002 |
| 52 |
FULL BLOOD COUNT DECREASED |
3 |
0.0001 |
| 53 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 54 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 55 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 56 |
PANCREATITIS ACUTE |
3 |
0.0001 |
| 57 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 58 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 59 |
CONCUSSION |
1 |
0.0001 |
| 60 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 61 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 62 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 63 |
EXPOSURE VIA SKIN CONTACT |
3 |
0.0001 |
| 64 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 65 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 66 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 67 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 68 |
HOSPICE CARE |
1 |
0.0001 |
| 69 |
POOR QUALITY DEVICE USED |
1 |
0.0001 |
| 70 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 71 |
INJURY ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 72 |
TRANSFUSION |
1 |
0.0001 |
| 73 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 74 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 75 |
MALNUTRITION |
1 |
0.0001 |
| 76 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 77 |
VASCULITIS |
1 |
0.0001 |
| 78 |
LOCALISED INFECTION |
2 |
0.0001 |
| 79 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 80 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 81 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 82 |
DEVICE BREAKAGE |
3 |
0.0001 |
| 83 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 84 |
APHONIA |
1 |
0.0001 |
| 85 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 86 |
SKIN REACTION |
1 |
0.0001 |
| 87 |
DEVICE ISSUE |
6 |
0.0001 |
| 88 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 89 |
LYMPHOMA |
1 |
0.0001 |
| 90 |
TENDONITIS |
1 |
0.0001 |
| 91 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
3 |
0.0001 |
| 92 |
BRAIN FOG |
1 |
0.0001 |
| 93 |
FEBRILE NEUTROPENIA |
4 |
0.0001 |
| 94 |
DEVICE USE ERROR |
2 |
0.0001 |
| 95 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 96 |
SYRINGE ISSUE |
1 |
0.0001 |
| 97 |
HYPOXIA |
2 |
0.0001 |
| 98 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 99 |
THINKING ABNORMAL |
1 |
0.0001 |
| 100 |
COLITIS |
2 |
0.0001 |
| 101 |
NEUTROPENIA |
7 |
0.0001 |
| 102 |
BONE PAIN |
3 |
0.0001 |
| 103 |
DYSPEPSIA |
5 |
0.0001 |
| 104 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 105 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 106 |
FEEDING DISORDER |
1 |
0.0000 |
| 107 |
ILLNESS |
5 |
0.0000 |
| 108 |
EATING DISORDER |
1 |
0.0000 |
| 109 |
WHITE BLOOD CELL COUNT DECREASED |
5 |
0.0000 |
| 110 |
PYREXIA |
15 |
0.0000 |
| 111 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 112 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 113 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 114 |
DYSGEUSIA |
3 |
0.0000 |
| 115 |
AGEUSIA |
1 |
0.0000 |
| 116 |
HYPOPHAGIA |
1 |
0.0000 |
| 117 |
HOSPITALISATION |
6 |
0.0000 |
| 118 |
ACCIDENTAL EXPOSURE TO PRODUCT |
4 |
0.0000 |
| 119 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 120 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 121 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 122 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 123 |
DYSSTASIA |
1 |
0.0000 |
| 124 |
PALPITATIONS |
4 |
0.0000 |
| 125 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 126 |
DISCOMFORT |
2 |
0.0000 |
| 127 |
HEAD INJURY |
1 |
0.0000 |
| 128 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 129 |
CYSTITIS |
1 |
0.0000 |
| 130 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 131 |
CHOLELITHIASIS |
1 |
0.0000 |
| 132 |
EYE DISORDER |
1 |
0.0000 |
| 133 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 134 |
HEART RATE INCREASED |
3 |
0.0000 |
| 135 |
GAIT INABILITY |
1 |
0.0000 |
| 136 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 137 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 138 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 139 |
CRYING |
1 |
0.0000 |
| 140 |
AGITATION |
2 |
0.0000 |
| 141 |
EPISTAXIS |
2 |
0.0000 |
| 142 |
DEATH |
23 |
0.0000 |
| 143 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 144 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 145 |
DRY MOUTH |
2 |
0.0000 |
| 146 |
BLINDNESS |
1 |
0.0000 |
| 147 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 148 |
ASTHENIA |
9 |
0.0000 |
| 149 |
HYPERHIDROSIS |
3 |
0.0000 |
| 150 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 151 |
ANGIOEDEMA |
1 |
0.0000 |
| 152 |
TACHYCARDIA |
2 |
0.0000 |
| 153 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 154 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 155 |
DECREASED APPETITE |
5 |
0.0000 |
| 156 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 157 |
ANAEMIA |
4 |
0.0000 |
| 158 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 159 |
INFECTION |
3 |
0.0000 |
| 160 |
SOMNOLENCE |
4 |
0.0000 |
| 161 |
CELLULITIS |
1 |
0.0000 |
| 162 |
FLUSHING |
2 |
0.0000 |
| 163 |
OFF LABEL USE |
17 |
0.0000 |
| 164 |
NERVOUSNESS |
1 |
0.0000 |
| 165 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 166 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 167 |
INFLUENZA |
2 |
0.0000 |
| 168 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 169 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 170 |
DYSPHONIA |
1 |
0.0000 |
| 171 |
SURGERY |
1 |
0.0000 |
| 172 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 173 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 174 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 175 |
DEHYDRATION |
2 |
0.0000 |
| 176 |
DRY SKIN |
2 |
0.0000 |
| 177 |
HYPOTENSION |
3 |
0.0000 |
| 178 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 179 |
SLEEP DISORDER |
1 |
0.0000 |
| 180 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 181 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 182 |
NAUSEA |
11 |
0.0000 |
| 183 |
UNDERDOSE |
1 |
0.0000 |
| 184 |
HOT FLUSH |
1 |
0.0000 |
| 185 |
FATIGUE |
10 |
0.0000 |
| 186 |
THROMBOSIS |
1 |
0.0000 |
| 187 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 188 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 189 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 190 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 191 |
ADVERSE EVENT |
1 |
0.0000 |
| 192 |
DIARRHOEA |
7 |
0.0000 |
| 193 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 194 |
WEIGHT DECREASED |
3 |
0.0000 |
| 195 |
BREAST CANCER |
1 |
0.0000 |
| 196 |
COUGH |
3 |
0.0000 |
| 197 |
SWELLING |
1 |
0.0000 |
| 198 |
MIGRAINE |
1 |
0.0000 |
| 199 |
PRURITUS |
4 |
0.0000 |
| 200 |
ALOPECIA |
2 |
0.0000 |
| 201 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 202 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 203 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 204 |
PNEUMONIA |
3 |
0.0000 |
| 205 |
RASH |
4 |
0.0000 |
| 206 |
CONSTIPATION |
2 |
0.0000 |
| 207 |
MALAISE |
4 |
0.0000 |
| 208 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 209 |
BACK PAIN |
2 |
0.0000 |
| 210 |
FEELING ABNORMAL |
2 |
0.0000 |
| 211 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 212 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 213 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 214 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 215 |
DIZZINESS |
3 |
0.0000 |
| 216 |
URTICARIA |
1 |
0.0000 |
| 217 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 218 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 219 |
COVID-19 |
1 |
0.0000 |
| 220 |
CHEST PAIN |
1 |
0.0000 |
| 221 |
DYSPNOEA |
3 |
0.0000 |
| 222 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 223 |
ERYTHEMA |
1 |
0.0000 |
| 224 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 225 |
HEADACHE |
3 |
0.0000 |
| 226 |
HYPERTENSION |
1 |
0.0000 |
| 227 |
VOMITING |
2 |
0.0000 |
| 228 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 229 |
PAIN |
2 |
0.0000 |
| 230 |
FALL |
1 |
0.0000 |
| 231 |
ARTHRALGIA |
1 |
0.0000 |
| 232 |
DRUG INEFFECTIVE |
3 |
0.0000 |